Author:
Liu Lei,Hao Xiaomeng,Song Zian,Zhi Xiangcheng,Zhang Sheng,Zhang Jin
Abstract
AbstractFamily history is a major risk factor for breast cancer; approximately 5–10% cases of breast cancer are associated with a family history. Herein, we investigated the link between family history and breast cancer features to elucidate the importance of family history in the diagnosis and treatment of breast cancer. Data from 10,549 patients with breast cancer were collected from 2014 to 2017. Detailed information about the family history of the patients including the degree and number of relatives affected and the types of cancer was recorded. The tumors were pathologically and clinically classified based on the stage, grade, ER, PR, HER2, Ki-67 status, and subtypes, according to standard guidelines. Data were analyzed using χ2 test and multiple logistic regression. Patients with a family history of other cancer types were significantly older at diagnosis than patients with a family history of breast/ovarian cancer (p = 0.002) and those without a family history of cancer (p < 0.001). Patients without a family history of cancer were typically diagnosed at a later stage, including high frequency in N2 (p = 0.035) and TNM stage III (p = 0.015). Compared with patients with second-/third-degree relatives, those with first-degree relatives having breast/ovarian cancer had a higher median age (54.1, p < 0.001) at diagnosis and showed more advanced disease. No significant difference was found between ER, PR, and HER2 status in patients with and without a family history of cancer. Family history of breast cancer can influence the cancer characteristics of the patients at diagnosis, especially patient age, tumor stage, and grade.
Funder
National Natural Science Foundation of China
Tianjin Science and Technology Program
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Organization, W. H. Latest global cancer data: Cancer burden rises to 18.1 million new cases and 9.6 million cancer deaths in 2018. International Agency for Research on Cancer (2018).
2. Howe, H. L. et al. Annual report to the nation on the status of cancer, 1975–2003, featuring cancer among US Hispanic/Latino populations. Cancer 107, 1711–1742. https://doi.org/10.1002/cncr.22193 (2006).
3. Engmann, N. J. et al. Population-attributable risk proportion of clinical risk factors for breast cancer. JAMA Oncol. 3, 1228–1236. https://doi.org/10.1001/jamaoncol.2016.6326 (2017).
4. Brewer, H. R., Jones, M. E., Schoemaker, M. J., Ashworth, A. & Swerdlow, A. J. Family history and risk of breast cancer: An analysis accounting for family structure. Breast Cancer Res. Treat. 165, 193–200. https://doi.org/10.1007/s10549-017-4325-2 (2017).
5. Diep, C. H., Daniel, A. R., Mauro, L. J., Knutson, T. P. & Lange, C. A. Progesterone action in breast, uterine, and ovarian cancers. J. Mol. Endocrinol. 54, R31-53. https://doi.org/10.1530/JME-14-0252 (2015).
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献